DTx Podcast with Eugene Borukhovich cover image

Ep65: Innovating Beyond Medication: The Intersection of Digital Therapeutics and Pharma

DTx Podcast with Eugene Borukhovich

00:00

The Challenges of a Drug Plus

I think some of the challenges and especially in pharma, pharmaceutical companies are great in producing smaller, large molecules. And then on the other side is quote unquote, let's call it the easier way to partner up with DTX companies when those stand alone. So a molecule plus a digital therapeutic is always a big challenge. But what point do you bring that in from a clinical trial perspective? How do you actually attribute sales and commercial traction once it's out in the marketplace? I'm curious how you guys are thinking about this or based on your earlier CYA.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app